Biotech · Private company
Myonex
Track this companyFree. Adds Myonex to your Dealase workspace and tells you when its record changes.
Clinical trials54 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials5
- Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)PHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07881952 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07637734 · fetched Nov 12, 2026
- Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)PHASE3 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07457918 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07246590 · fetched Nov 12, 2026
- Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05188729 · fetched Nov 12, 2026